Version June 2024
| Population | Recommendations |
| Culprit vessel revascularized with angiographic disease of uncertain functional significance in one or more remaining vessels | SPECT or PET perfusion imaging or stress echocardiography |
| NSTEACS patients with unexplained dyspnea, mitral regurgitation, or mild to moderate aortic stenosis | Exercise echocardiography with Doppler imaging |
| LV systolic dysfunction and/or large infarct territory with question of viability | Dobutamine echocardiography, SPECT, PET, or MRI with viability protocol |
| Higher-risk patients undergoing predischarge testing early after infarction | Vasodilator SPECT or PET imaging |
| Low-risk subjects in whom the diagnosis of ACS is uncertain or with biomarker elevation likely not due to ACS | SPECT or PET perfusion imaging or stress echocardiography |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
